关注
Pilar Retamar-Gentil
Pilar Retamar-Gentil
Enfermedades Infecciosas. HUV Macarena. Universidad de Sevilla. Instituto Biosanitario de Sevilla
在 juntadeandalucia.es 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey
A Versporten, P Zarb, I Caniaux, MF Gros, N Drapier, M Miller, V Jarlier, ...
The Lancet Global Health 6 (6), e619-e629, 2018
6172018
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli …
M Paul, E Carrara, P Retamar, T Tängdén, R Bitterman, RA Bonomo, ...
Clinical Microbiology and Infection 28 (4), 521-547, 2022
5042022
Escherichia coli: an old friend with new tidings
J Vila, E Sáez-López, JR Johnson, U Römling, U Dobrindt, R Cantón, ...
FEMS microbiology reviews 40 (4), 437-463, 2016
4192016
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachon, ...
Clinical Microbiology and Infection 26 (11), 1525-1536, 2020
3682020
β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli: A Post Hoc …
J Rodriguez-Bano, MD Navarro, P Retamar, E Picon, A Pascual, ...
Clinical Infectious Diseases 54 (2), 167-174, 2012
3602012
Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis
P Retamar, MM Portillo, MD López-Prieto, F Rodríguez-López, ...
Antimicrobial agents and chemotherapy 56 (1), 472-478, 2012
2442012
Extended-Spectrum Beta-Lactamases–Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group. β-Lactam/β-lactam inhibitor …
J Rodríguez-Baño, MD Navarro, P Retamar, E Picón, Á Pascual
Clin Infect Dis 54 (2), 167-174, 2012
1842012
Epidemiology and clinical features of community‐acquired, healthcare‐associated and nosocomial bloodstream infections in tertiary‐care and community hospitals
J Rodríguez‐Baño, MD López‐Prieto, MM Portillo, P Retamar, C Natera, ...
Clinical Microbiology and Infection 16 (9), 1408-1413, 2010
1702010
Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli
P Retamar, L López-Cerero, MA Muniain, Á Pascual, J Rodríguez-Baño, ...
Antimicrobial agents and chemotherapy 57 (7), 3402-3404, 2013
1102013
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients
M Bartoletti, M Giannella, R Lewis, P Caraceni, S Tedeschi, M Paul, ...
Clinical Microbiology and Infection 24 (5), 546. e1-546. e8, 2018
1002018
Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): Results from a worldwide point prevalence …
I Pauwels, A Versporten, N Drapier, E Vlieghe, H Goossens
Journal of Antimicrobial Chemotherapy 76 (6), 1614-1624, 2021
932021
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial
J Molina, E Montero-Mateos, J Praena-Segovia, E León-Jiménez, ...
Clinical Microbiology and Infection 28 (4), 550-557, 2022
912022
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
B Gutiérrez-Gutiérrez, MD Del Toro, AM Borobia, A Carcas, I Jarrín, ...
The Lancet infectious diseases 21 (6), 783-792, 2021
802021
Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and …
J Rodríguez-Baño, JM Cisneros, N Cobos-Trigueros, G Fresco, ...
Enfermedades infecciosas y microbiologia clinica 33 (5), 337. e1-337. e21, 2015
792015
A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance
JM López-Lozano, T Lawes, C Nebot, A Beyaert, X Bertrand, D Hocquet, ...
Nature Microbiology 4 (7), 1160-1172, 2019
772019
Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum β-lactamase-producing Escherichia coli in the …
G Peñalva, R Fernández-Urrusuno, JM Turmo, R Hernández-Soto, ...
The Lancet Infectious Diseases 20 (2), 199-207, 2020
712020
Current management of bloodstream infections
J Rodriguez-Bano, M De Cueto, P Retamar, J Galvez-Acebal
Expert review of anti-infective therapy 8 (7), 815-829, 2010
702010
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Q Zhang, A Pizzorno, L Miorin, P Bastard, A Gervais, T Le Voyer, L Bizien, ...
Journal of Experimental Medicine 219 (11), e20220514, 2022
632022
Effectiveness of fosfomycin for the treatment of multidrug-resistant Escherichia coli bacteremic urinary tract infections: a randomized clinical trial
J Sojo-Dorado, I López-Hernández, C Rosso-Fernandez, IM Morales, ...
JAMA network open 5 (1), e2137277-e2137277, 2022
582022
Management of bloodstream infections by infection specialists: an international ESCMID cross-sectional survey
K Diallo, N Thilly, A Luc, G Beraud, Ö Ergonul, M Giannella, D Kofteridis, ...
International journal of antimicrobial agents 51 (5), 794-798, 2018
582018
系统目前无法执行此操作,请稍后再试。
文章 1–20